We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Boston Properties
BXP
$11.1B
| $15.8M | 0.03% |
274,572
-162,913
| -37% | -$8.47M |
|
|
BWCAW
552
CALL
DELISTED
Blue Whale Acquisition Corp I Warrant
BWCAW
| $15.7M | 0.03% |
219,105
| – | – |
|
553
ExxonMobil
XOM
$634B
| $15.7M | 0.03% |
146,205
-302,129
| -67% | -$33M |
|
554
The Mosaic Company
MOS
$7.33B
| $15.7M | 0.03% |
447,809
-512,110
| -53% | -$19.8M |
|
555
Synchrony
SYF
$25.6B
| $15.6M | 0.03% |
461,262
-15,522
| -3% | -$474K |
|
556
DHT Holdings
DHT
$3.02B
| $15.6M | 0.03% |
1,830,274
+1,333,036
| +268% | +$11.7M |
|
|
SNCY
557
DELISTED
Sun Country Airlines
SNCY
| $15.6M | 0.03% |
693,280
-22,435
| -3% | -$428K |
|
558
Dr. Reddy's Laboratories
RDY
$10.2B
| $15.6M | 0.03% |
1,234,560
+1,098,810
| +809% | +$12.8M |
|
559
Pacira BioSciences
PCRX
$997M
| $15.6M | 0.03% |
388,297
+69,136
| +22% | +$2.86M |
|
560
MasterBrand
MBC
$1.91B
| $15.5M | 0.03% |
1,335,742
+1,058,528
| +382% | +$10.2M |
|
561
Viridian Therapeutics
VRDN
$2.67B
| $15.5M | 0.03% |
651,179
+21,859
| +3% | +$561K |
|
562
Liberty Broadband Class C
LBRDK
$5.15B
| $15.5M | 0.03% |
193,133
+2,293
| +1% | +$177K |
|
563
PUT
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
| $15.5M | 0.03% |
458,800
-2,221,500
| -83% | -$72.5M |
|
|
EA
564
DELISTED
Electronic Arts
EA
| $15.4M | 0.03% |
119,065
-145,020
| -55% | -$18.4M |
|
565
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
| $15.4M | 0.03% |
181,302
+149,098
| +463% | +$11.4M |
|
566
Ulta Beauty
ULTA
$24.3B
| $15.4M | 0.03% |
32,674
-224,399
| -87% | -$110M |
|
|
NARI
567
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $15.3M | 0.03% |
263,576
-131,857
| -33% | -$8.32M |
|
568
Healthcare Services Group
HCSG
$1.53B
| $15.3M | 0.03% |
1,026,013
-748,380
| -42% | -$10.8M |
|
569
SI-BONE Inc
SIBN
$834M
| $15.3M | 0.03% |
+565,389
| New | +$13.8M |
|
570
Integra LifeSciences
IART
$1.34B
| $15.2M | 0.03% |
+370,288
| New | +$17.8M |
|
571
Commault Systems
CVLT
$5.61B
| $15.2M | 0.03% |
209,562
+91,738
| +78% | +$5.96M |
|
572
LKQ Corp
LKQ
$6.29B
| $15.1M | 0.03% |
+259,182
| New | +$14.4M |
|
573
DigitalBridge
DBRG
$2.95B
| $15.1M | 0.03% |
+1,026,475
| New | +$12.6M |
|
574
Dolby
DLB
$5.79B
| $15M | 0.03% |
179,398
+93,275
| +108% | +$7.8M |
|
575
West Pharmaceutical
WST
$24.9B
| $14.8M | 0.03% |
38,767
-19,272
| -33% | -$6.88M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.